Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Nephrology / Urology
Healthy:No
Age Range:Any - 18
Updated:4/21/2016
Start Date:June 2006
End Date:December 2010

Use our guide to learn which trials are right for you!

Assessment of Gene and Urinary Protein Expression in Aminoglycoside-treated and Untreated Infants, Children and Adolescents

The purposes of this study are to identify potential gene and protein markers of
aminoglycoside-induced kidney injury in infants, children and adolescents treated with
aminoglycoside antibiotics.


Inclusion Criteria: (1) Hospitalized male and female newborns, infants, children and
adolescents (ages birth to 18 years) with a diagnosis of suspected or proven bacterial
sepsis, meningitis or other indication necessitating aminoglycoside therapy (2)
hospitalized and outpatient newborns, infants, children and adolescents (ages birth to 18
years) who are not receiving aminoglycoside therapy.

Exclusion Criteria: (1) Current treatment with inhaled or ophthalmic aminoglycosides (2)
Prior treatment with an aminoglycoside within the last 30 days
We found this trial at
2
sites
Richmond, Virginia 23298
(804) 828-0100
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
?
mi
from
Richmond, VA
Click here to add this to my saved trials
318 West Brandeis Avenue
Louisville, Kentucky 40202
?
mi
from
Louisville, KY
Click here to add this to my saved trials